Trial
NCT02767232
Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
RTI International; Mid America Heart Institute; National Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.
Condition
Deep Vein Thrombosis
Intervention
Recombinant tissue plasminogen activator (rt-PA)
Why stopped
Did not receive NIH Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-10